Dose-volumetric Predictors for Thyroid Dysfunction after 3D Conformal Radiotherapy: An Observational, Prospective Study

Main Article Content

M. Al-Jamal
A. Abd Elnaby
A. El-Badrawy
H. M. H. R. Elkalla
R. Omar
E. Abdallah

Abstract

Aim: This study was conducted to assess the dose-volumetric threshold of radiation induced hypothyroidism (RIHT) in patients receiving radiotherapy (RT) to the neck.

Study Design: This is a prospective cohort observational study.

Place and Duration of the Study: The study was conducted at Mansoura University Hospital, Mansoura, Egypt, between April 2016 until March 2019.

Methods: We have completed 2 years of follow up to 50 patients with different malignancies who were treated by radiotherapy to the neck. Baseline assessment of the thyroid clinically and radiologically was done prior to the start of radiotherapy. Periodic testing of the cohort through the follow up period was done by clinical examination, measurement of TSH, fT4 and thyroid ultrasonography.

Results: the incidence of RIHT was 26%. No statistical significance for the clinical risk factors. The dose-volumetric risk factors were studied and showed positive results. A mean dose of 5185 cGy was found a significant risk factor. Also, V40 ≥ 89%, V45 ≥ 63.5%, V50 ≥ 22.5% were found to be the cutoff predictors for the threshold radiation dose to induce hypothyroidism. Also decreasing the size of the gland by ≥0.7 cm3, fT4 value by ≥ 3.5 pmol/L and TSH by ≥ 0.75 uIU/L after one year from the end of EBRT is the cutoff value for prediction of occurrence of RIHT within the 2nd year of follow up.

Conclusion: RIHT is a considerable late adverse effect for patients receiving RT to the neck. Mean dose, V40, V45 and V50 were found significantly related to RIHT. Mean dose of ≥ 5185 cGy, V40 ≥ 89%, V45 ≥ 63.5%, V50≥ 22.5% were proven to be the dose-volumetric threshold.

Keywords:
Radiotherapy, hypothyroidism, prospective, cohort, predictors.

Article Details

How to Cite
Al-Jamal, M., Elnaby, A. A., El-Badrawy, A., Elkalla, H. M. H. R., Omar, R., & Abdallah, E. (2020). Dose-volumetric Predictors for Thyroid Dysfunction after 3D Conformal Radiotherapy: An Observational, Prospective Study. Journal of Cancer and Tumor International, 9(4), 1-12. https://doi.org/10.9734/jcti/2019/v9i430116
Section
Original Research Article

References

Aggarwal K, et al. Radiation induced hypothyroidism - Why is early intervention necessary? Oral Oncol. 2019;104444.

Kamal M, et al. Radiation-induced hypothyroidism after radical intensity modulated radiation therapy for oropharyn-geal carcinoma. Adv Radiat Oncol. 2020; 5(1):111-119.

Rao D, Shah S. Thyroid dysfunction following management of non-thyroid head and neck cancers. Indian J Otolaryngol Head Neck Surg. 2019;71(Suppl 1):447-452.

Luo R, et al. Nomogram for radiation-induced hypothyroidism prediction in nasopharyngeal carcinoma after treatment. Br J Radiol. 2017;90(1070):20160686.

Laway B, et al. Incidence of primary hypothyroidism in patients exposed to therapeutic external beam radiation, where radiation portals include a part or whole of the thyroid gland. 2012;16(Suppl 2):S329.

Sawka AM, et al. Patient context and TSH levels are important when considering treatment of subclinical hypothyroidism; 2019.

Sawka AM, et al. American thyroid association guidelines and statements: Past, present, and future: American Thyroid Association Guidelines Policy and Procedures Task Force. 2018;28(6):692-706.

Cheng SCH, et al. Sonographic appearance of thyroid glands in patients treated with intensity-modulated radio-therapy or conventional radiotherapy for nasopharyngeal carcinoma. J Clin Ultrasound. 2015;43(4):210-223.

Bruzzaniti V, et al. IsoBED: A tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique. 2011;30(1):52.

Metz CE. Basic principles of ROC analysis. in Seminars in nuclear medicine. Elsevier; 1978.

Griner P, Mayewski R, Mushlin A, Greenland P. Selection and interpretation of diagnostic tests and procedures. Annals of Internal Medicine. 1981;94:555-600.

Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association. 1958;53(282):457-481.

Kumpulainen EJ, et al. Hypothyroidism after radiotherapy for laryngeal cancer. 2000;57(1):97-101.

Lee V, et al. Dosimetric predictors of hypothyroidism after radical intensity-modulated radiation therapy for non-metastatic nasopharyngeal carcinoma. 2016;28(8):e52-e60.

Prpic M, et al. Dose-volume derived nomogram as a reliable predictor of radiotherapy-induced hypothyroidism in head and neck cancer patients. Radiol Oncol. 2019;53(4):488-496.

El-Shebiney M, et al. Radiotherapeutic factors affecting the incidence of developing hypothyroidism after radio-therapy for head and neck squamous cell cancer. 2018;30(1):33-38.

Boomsma MJ, et al. A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model. 2012;84(3):e351-e356.

Feen Ronjom M. Radiation-induced hypothyroidism after treatment of head and neck cancer. Dan Med J. 2016;63(3).

Cella L, et al. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin’s lymphoma. 2012;82(5):1802-1808.

Chyan A, et al. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy. 2014;9(1):269.

Mercado G, et al. Hypothyroidism: A frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer, 2001;92(11):2892-7.

Tell R, et al. Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. 2004; 60(2):395-400.

Kim MY, Yu T, Wu HGJJJOCO. Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer. 2014;44(4):331-337.

Grande CJR. Oncology, hypothyroidism following radiotherapy for head and neck cancer: Multivariate analysis of risk factors. 1992;25(1):31-36.

Hancock SL, McDougall IR, L.S.J.I.J.o.R.O.B.P. Constine, thyroid abnormalities after therapeutic external radiation. 1995;31(5):1165-1170.

Koc M, Capoglu IJAJOCO. Thyroid dysfunction in patients treated with radiotherapy for neck. 2009;32(2):150-153.

Bakhshandeh M, et al. Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy. 2013; 85(2):514-521.

Zhai RP, et al. Radiation-induced hypothyroidism after IMRT for naso-pharyngeal carcinoma: Clinical and dosimetric predictors in a prospective cohort study. 2017;68:44-49.

Miller-Thomas M, et al. The shrinking thyroid: How does thyroid size change following radiation therapy for laryngeal cancer? 2009;30(3):613-616.

Bonato C, et al. Reduced thyroid volume and hypothyroidism in survivors of childhood cancer treated with radio-therapy. 2008;21(10):943-950.

Lin Z, et al. Pattern of radiation-induced thyroid gland changes in nasopharyngeal carcinoma patients in 48 months after radiotherapy. PLoS One. 2018;13(7): e0200310.